HBAR Price Prediction Gains After Merck Partnership While Pepeto Builds What HBAR Cannot Offer

Merck’s Hedera integration to power EU pharma supply chain tracking adds real enterprise volume for HBAR, as price hovers around $0.082 and eyes potential upside from ongoing partnerships. The piece also highlights Pepeto’s $10.2M presale, Binance listing anticipation, and tools like PepetoSwap and a risk-scoring contract scanner, suggesting betting on new token infrastructure alongside Hedera adoption. Overall, it contrasts enterprise adoption with meme-token momentum, underscoring HBAR’s dependence on on-chain usage for price movement.